Table of Contents Table of Contents
Previous Page  29 / 86 Next Page
Information
Show Menu
Previous Page 29 / 86 Next Page
Page Background

27

NCCN Guidelines for Patients

®

Peripheral T-cell Lymphoma, Version 1.2016

3

Overview of cancer treatments Chemotherapy

Chart 3.1 Drug treatment for peripheral T-cell lymphoma

Generic name

Brand name (sold as)

Type of treatment

Alemtuzumab

Campath

®

Targeted therapy

Belinostat

Beleodaq

®

Targeted therapy

Bendamustine hydrochloride

Treanda

®

Chemotherapy

Bortezomib

Velcade

®

Chemotherapy

Brentuximab vedotin

Adcetris

®

Targeted therapy

Carboplatin

Chemotherapy

Cisplatin

Platinol

®

Chemotherapy

Cyclophosphamide

Chemotherapy

Cyclosporine

Neoral

®

, Sandimmune

®

Cytarabine

Cytosar-U

®

Chemotherapy

Dexamethasone, Dexamethasone

sodium phosphate

Steroid

Doxorubicin hydrochloride

Chemotherapy

Doxorubicin hydrochloride, Liposomal

injection

Doxil

®

Chemotherapy

Epirubicin hydrochloride

Ellence

®

Chemotherapy

Etoposide; Etoposide phosphate

Etopophos

®

Preservative Free Chemotherapy

Gemcitabine hydrochloride

Gemzar

®

Chemotherapy

Ifosfamide

Chemotherapy

Lenalidomide

Revlimid

®

Immunomodulator

Leucovorin calcium

Folic acid analog

Mesna

Mesnex

®

Injection

Chemoprotectant

Methotrexate; Methotrexate sodium –

Chemotherapy

Methylprednisolone;

Methylprednisolone acetate;

Methylprednisolone sodium succinate

A-Methepred

®

, Depo-Medrol

®

,

Medrol

®

, Solu-Medrol

®

Steroid

Oxaliplatin

Eloxatin

®

Chemotherapy

Pralatrexate

Folotyn

®

Chemotherapy

Prednisone

Steroid

Romidepsin

Istodax

®

Chemotherapy

Vincristine sulfate

Chemotherapy

Vinorelbine tartrate

Navelbine

®

Chemotherapy